CurrentEndo
Get Weekly

CurrentEndo coverage · page 22 of 55

Diabetes, Obesity and Metabolism

Briefs 841–880 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Body mass index and mental disorders: A Danish cohort study

    Cohort studyObesity

  2. Diabetes Obes Metab

    Glucagon‐like peptide‐1 receptor agonist and respiratory complications after endoscopy: A Japanese nationwide cohort study

    Cohort studyT2D & other

  3. Diabetes Obes Metab

    Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study

    Cohort studyObesity

  4. Diabetes Obes Metab

    A systematic literature review and meta‐analysis of real‐world evidence on commercially available automated insulin delivery systems in people with type 1 diabetes

    Meta-analysisTechnology

  5. Diabetes Obes Metab

    Addressing the risk of ocular complications of GLP ‐ 1RAs ; a multi‐disciplinary expert consensus

    Guideline or statementComplications

  6. Diabetes Obes Metab

    Evaluating global epidemiology of type 2 diabetes mellitus among the working‐age population: A 60‐year study by interpretable machine learning framework

    Research articleT2D & other

  7. Diabetes Obes Metab

    Histological efficacy of anti‐diabetic agents in MASH and the mediating role of weight loss: A network meta‐analysis

    Meta-analysisLipids & liver

  8. Diabetes Obes Metab

    Relative efficacy of GLP ‐1 and GLP ‐1/ GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach

    Cohort studyT2D & other

  9. Diabetes Obes Metab

    Efficacy and safety of once‐weekly basal insulin therapy in people with type 1 diabetes: A systematic review and meta‐analysis

    Meta-analysisT1D

  10. Diabetes Obes Metab

    Reevaluating the causal link between liver fat and hyperglycaemia

    Meta-analysisT2D & other

  11. Diabetes Obes Metab

    Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial

    Trial designT1D

  12. Diabetes Obes Metab

    Weight loss in people with type 1 diabetes over 12 months: Real‐world data comparing tirzepatide, semaglutide and liraglutide

    Cohort studyT1D

  13. Diabetes Obes Metab

    Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes

    Meta-analysisT2D & other

  14. Diabetes Obes Metab

    Association between accelerometer‐measured physical activity, genetic risk, and incident type 2 diabetes: A prospective cohort study

    Cohort studyT2D & other

  15. Diabetes Obes Metab

    Contributions of intermittently scanned continuous glucose monitoring frequency and bolus insulin dosing on time in range: Analysis of data from CGM and connected insulin pens

    Cohort studyTechnology

  16. Diabetes Obes Metab

    Pre‐conception weight loss interventions in women with polycystic ovary syndrome and the effect on perinatal outcomes: A quantitative synthesis of surrogate outcomes

    Meta-analysisReproductive endocrine

  17. Diabetes Obes Metab

    Tryptophan derivatives as non‐invasive diagnostic indicators for obesity‐related MASLD in children and adolescents

    Diagnostic or prognostic studyObesity

  18. Diabetes Obes Metab

    Shared and divergent acute cardiovascular risk protein responses to lipid infusion in women with and without PCOS

    Randomized controlled trialReproductive endocrine

  19. Diabetes Obes Metab

    Comparative cardiovascular risk of sulfonylureas with low‐ and high‐affinities for cardiac mitochondrial adenosine triphosphate‐sensitive potassium channels versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A cohort study

    Cohort studyT2D & other

  20. Diabetes Obes Metab

    Risk of depression with GLP ‐1 receptor agonists use in overweight or obese adults with type 2 diabetes: A new‐user, active‐comparator cohort study

    Cohort studyT2D & other

  21. Diabetes Obes Metab

    An interpretable machine learning model for predicting metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes

    Cohort studyLipids & liver

  22. Diabetes Obes Metab

    Tirzepatide and the 10‐year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three‐year SURMOUNT ‐1 trial

    Secondary analysisObesity

  23. Diabetes Obes Metab

    Glycaemic control and variability with different commercially available hybrid closed loop systems in people with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials

    Meta-analysisT1D

  24. Diabetes Obes Metab

    Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER ‐2 trial emulation with real‐world data

    Cohort studyT2D & other

  25. Diabetes Obes Metab

    Probiotics and dietary fibre fermented milk supplementation initiated in the first trimester to prevent gestational diabetes mellitus in overweight and obese pregnant women: A randomized controlled trial

    Randomized controlled trialDiabetes in pregnancy

  26. Diabetes Obes Metab

    Diabetes remission and diabetic complications of bariatric surgery vs. medical management in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials

    Meta-analysisObesity

  27. Diabetes Obes Metab

    Plasma sphingolipids predict advanced liver fibrosis development in patients with type 2 diabetes

    Cohort studyT2D & other

  28. Diabetes Obes Metab

    Genetic evidence for repurposing GLP‐1 receptor agonists in chronic kidney disease and IgA nephropathy: Metabolic and anti‐inflammatory pathways beyond glycaemic control

    Research articleT2D & other

  29. Diabetes Obes Metab

    Phase I study of the oral GLP ‐1 receptor agonist DA ‐ 302168S : Safety, pharmacokinetics, and pharmacodynamics in healthy and overweight/obese adults

    Randomized controlled trialObesity

  30. Diabetes Obes Metab

    Efficacy and safety of Efsubaglutide Alfa in “overrun” patients in the SUPER2 trial: A post‐hoc analysis for comprehensive evaluation

    Secondary analysisT2D & other

  31. Diabetes Obes Metab

    Unveiling urinary diagnostic biomarkers for diabetic kidney disease using metabolomics and machine learning approaches

    Diagnostic or prognostic studyComplications

  32. Diabetes Obes Metab

    Empagliflozin for the preservation of beta‐cell function in women with recent gestational diabetes: A randomized placebo‐controlled trial

    Randomized controlled trialDiabetes in pregnancy

  33. Diabetes Obes Metab

    Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes

    Cohort studyT2D & other

  34. Diabetes Obes Metab

    Discrepancies between current displayed and auto‐logged glucose values in FreeStyle Libre 3: Implications for clinical interpretation

    Secondary analysisTechnology

  35. Diabetes Obes Metab

    Optimizing cardiovascular health with a type 2 diabetes remission program: Ultraprocessed food‐intake reduction, Mediterranean diet, chrononutrition and physical training—The DIABEPIC ‐2 pilot study

    Research articleT2D & other

  36. Diabetes Obes Metab

    Coated glucose microbeads stimulate enteric hormone release and improve glucose tolerance in Phase 1 and 2 clinical trials

    Randomized controlled trialT2D & other

  37. Diabetes Obes Metab

    A 7‐year prospective analysis of sustained benefits of multicomponent risk assessment and data‐driven care in patients with type 2 diabetes: The Malaysian JADE Program

    Randomized controlled trialT2D & other

  38. Diabetes Obes Metab

    Combined agonism of nutrient receptors GPR40 and GPR119 with K‐757 and K‐833 results in weight loss and blood pressure reductions in obese subjects without type 2 diabetes mellitus

    Randomized controlled trialObesity

  39. Diabetes Obes Metab

    Contributions of 2‐h post‐load glucose, fasting blood glucose and glycosylated haemoglobin elevations to the prevalence of diabetes and pre‐diabetes in adults: A systematic analysis of global data

    Meta-analysisT2D & other

  40. Diabetes Obes Metab

    Dapagliflozin restores odour‐induced functional integration of primary olfactory cortex circuit but not olfactory‐related regional brain activation in patients with type 2 diabetes: A 16‐week randomised comparative study

    Randomized controlled trialT2D & other

All 2,200 Briefs in ExploreShowing Briefs 841–880 of 2,200, newest first